BindingDB

The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 3.0M data for 1.3M Compounds and 9.6K Targets. Of those, 1.5M data for 695K Compounds and 4.7K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

Donate Now

Advanced Search

5 articles for thisTarget

The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
Progress in Discovery of KIF5B-RET Kinase Inhibitors for the Treatment of Non-Small-Cell Lung Cancer.EBI
Daegu-Gyeongbuk Medical Innovation Foundation (Dgmif)
Discovery of 2-((4-resorcinolyl)-5-aryl-1,2,3-triazol-1-yl)acetates as potent Hsp90 inhibitors with selectivity over TRAP1.EBI
Daegu-Gyeongbuk Medical Innovation Foundation (Dgmif)
DNA-Encoded Library Screening as Core Platform Technology in Drug Discovery: Its Synthetic Method Development and Applications in DEL Synthesis.EBI
Daegu-Gyeongbuk Medical Innovation Foundation (Dgmif)
Recent developments in small molecule therapies for renal cell carcinoma.EBI
Daegu-Gyeongbuk Medical Innovation Foundation (Dgmif)
Recent Progress in the Development of Transglutaminase 2 (TGase2) Inhibitors.EBI
Daegu-Gyeongbuk Medical Innovation Foundation (Dgmif)